Worried about the State Pension? I think the GSK share price could help you retire early

I think GlaxoSmithKline plc (LON: GSK) may offer improving growth prospects that could help overcome a rising State Pension age.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Close-up Of A Piggybank With Eyeglasses And Calculator On Desk

Image source: Getty Images

The rising State Pension age is likely to be a continuing concern for people of all ages, as it’s due to increase to 68 over the next two decades. As such, buying good value shares that offer growth potential could be a sound means of generating a sizeable nest egg by the time retirement arrives.

One stock that could offer those two attributes is GlaxoSmithKline (LSE: GSK). The FTSE 100 pharma stock is in the process of delivering a new strategy, while its income growth prospects could improve. Alongside another dividend growth share which reported improving results on Wednesday, it could be worth buying for the long term.

Inflation Is Coming

Inflation is out of control, and people are running scared. But right now there’s one thing we believe Investors should avoid doing at all costs… and that’s doing nothing. That’s why we’ve put together a special report that uncovers 3 of our top UK and US share ideas to try and best hedge against inflation… and better still, we’re giving it away completely FREE today!

Click here to claim your copy now!

Improving prospects

The company in question is engineering and construction specialist Balfour Beatty (LSE: BBY). Its full-year results showed an increase in underlying pre-tax profit of 10% to £181m. It was able to achieve industry-standard margins in the second half of 2018, with gross debt declining by over 40%. It now has a higher quality order book, increasing 11% to £12.6bn. This suggests it’s experiencing improved operating conditions, and may be able to generate stronger financial performance in the long run.

Looking ahead, Balfour Beatty is expected to post a rise in net profit of 22% in the current year. It trades on a price-to-earnings growth (PEG) ratio of 0.7, which suggests it could offer a wide margin of safety. Alongside this, it’s expected to increase dividends by 81% in 2019, which puts it on a yield of 2.3%. Since dividends are covered 3.4 times by profit, they could grow at a fast pace. This may help to catalyse the company’s share price performance over the long run.

Changing business

While GlaxoSmithKline has experienced a mixed recent past, its future appears to be bright. Under a new CEO it’s in the process of refocusing on its pharma segment, with M&A activity enhancing its capabilities in this area. It has also decided to pivot away from its consumer healthcare business, which may provide it with greater efficiency and focus as it seeks to compete in what could prove to be a highly lucrative pharma industry.

With the world’s population continuing to increase in terms of size and age, the company could be well-placed to benefit from a tailwind over the long run. Its dividend potential remains high, with shareholder payouts currently covered 1.5 times by profit. Having frozen dividend growth in recent years, a positive earnings growth outlook suggests that there may be a return to rising dividends over the medium term.

Since the State Pension age is forecast to rise, GlaxoSmithKline could offer a potent mix of income and growth appeal. Trading on a price-to-earnings (P/E) ratio of 13, it appears to offer good value for money when compared to its large-cap healthcare industry peers. As such, now could be the right time to buy it.

More on Investing Articles

Passive and Active: text from letters of the wooden alphabet on a green chalk board
Investing Articles

2 undervalued passive income stocks I’d buy today with £1,000

Falling stock prices are pushing up dividend yields. As a result, our author is looking for undervalued passive income stocks…

Read more »

Close-up of British bank notes
Investing Articles

2 cheap dividend shares I’d buy in a heartbeat

Our writer picks a pair of FTSE 100 dividend shares he would consider for his portfolio, that he thinks look…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

With £500, I’d use the Warren Buffett method to find cheap shares

The legendary investor Warren Buffett has become a billionaire by following some key investment principles. Our writer explains why he…

Read more »

Man in a clothing store in a medical mask because of a coronovirus.
Investing Articles

Down 81%, are boohoo shares set for an explosive comeback?

boohoo shares have been falling rapidly. But could interest from a billion-dollar hedge fund cause a turnaround in 2022?

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

The Tullow Oil (TLW) share price jumps after losses! Is now the time to buy?

The Tullow Oil (TLW) share price ticked upwards on Thursday morning after falling nearly 30% over the last month. So,…

Read more »

Female analyst sat at desk looking at pie charts on paper
Investing Articles

Is the Lloyds share price about to dip below 40p?

The Lloyds share price has been trading below 50p for the better part of the year. But could the stock…

Read more »

Cheerful young businesspeople with laptop working in office
Investing Articles

2 beaten-down FTSE 250 shares I’m buying and holding for the long term

Andrew Woods explains why he's adding two FTSE 250 shares to his portfolio in the middle of a market sell-off.

Read more »

Female analyst sat at desk looking at pie charts on paper
Investing Articles

The Legal & General (LGEN) share price jumps 3%! Am I too late to buy?

The Legal & General (LGEN) share price soared in early trading on Thursday as the company registered a good start…

Read more »